Austria · Who invested in Nabriva Therapeutics?
Nabriva Therapeutics's investors include OrbiMed, Novartis Venture Fund, Vivo Capital, Wellcome Trust and HBM BioVentures, and 3 more on record.
Austria · Series B startup
Who invested in Nabriva Therapeutics
One round we have observed, with the 8 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$22Mraised across 1 round since 2010, from 1 source
- Latest round
- Series B, $22MJan 2010
- Investors
- 8
The rounds
- Jan 2010Series B$22M
OrbiMed
Novartis Venture Fund
Vivo Capital
Wellcome Trust- HBM BioVentures
EcoR1 Capital
Phase4 Partners- GLS Ventures
Reported by onbiovc.com
Everyone who backed them
HBM BioVenturesGrowth equity1round
GLS Venturesno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Nabriva Therapeutics
How much has Nabriva Therapeutics raised?
Nabriva Therapeutics has raised $22M across 1 round since 2010.
When did Nabriva Therapeutics last raise?
Nabriva Therapeutics's most recent round was a Series B of $22M in Jan 2010.
What was Nabriva Therapeutics's biggest round?
Its most recent round, $22M in Jan 2010, is also its largest on record.
Who backed Nabriva Therapeutics first?
Nabriva Therapeutics's first round on record, in Jan 2010, was backed by OrbiMed, Novartis Venture Fund and Vivo Capital and 5 others.
What stage is Nabriva Therapeutics at?
Nabriva Therapeutics's latest named round is a Series B, in Jan 2010.
Where is Nabriva Therapeutics based?
Nabriva Therapeutics is based in Austria.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.